- Home
- ATNM vs JRSH Comparison
ATNM vs JRSH Comparison
Compare ATNM & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- JRSH
- Stock Information
- Founded
- ATNM 2000
- JRSH 2016
- Country
- ATNM United States
- JRSH United States
- Employees
- ATNM N/A
- JRSH N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- JRSH Apparel
- Sector
- ATNM Health Care
- JRSH Consumer Discretionary
- Exchange
- ATNM Nasdaq
- JRSH Nasdaq
- Market Cap
- ATNM 49.0M
- JRSH 41.7M
- IPO Year
- ATNM N/A
- JRSH 2018
- Fundamental
- Price
- ATNM $1.72
- JRSH $3.36
- Analyst Decision
- ATNM Strong Buy
- JRSH Strong Buy
- Analyst Count
- ATNM 2
- JRSH 1
- Target Price
- ATNM $4.50
- JRSH $4.00
- AVG Volume (30 Days)
- ATNM 176.2K
- JRSH 26.8K
- Earning Date
- ATNM 08-08-2025
- JRSH 08-12-2025
- Dividend Yield
- ATNM N/A
- JRSH 5.94%
- EPS Growth
- ATNM N/A
- JRSH N/A
- EPS
- ATNM N/A
- JRSH 0.07
- Revenue
- ATNM N/A
- JRSH $144,505,598.00
- Revenue This Year
- ATNM N/A
- JRSH $5.56
- Revenue Next Year
- ATNM N/A
- JRSH $8.41
- P/E Ratio
- ATNM N/A
- JRSH $51.29
- Revenue Growth
- ATNM N/A
- JRSH 17.11
- 52 Week Low
- ATNM $1.03
- JRSH $2.81
- 52 Week High
- ATNM $2.41
- JRSH $4.17
- Technical
- Relative Strength Index (RSI)
- ATNM 54.44
- JRSH 52.61
- Support Level
- ATNM $1.60
- JRSH $3.33
- Resistance Level
- ATNM $1.79
- JRSH $3.40
- Average True Range (ATR)
- ATNM 0.10
- JRSH 0.05
- MACD
- ATNM 0.01
- JRSH -0.00
- Stochastic Oscillator
- ATNM 76.25
- JRSH 44.75
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.